1. Home
  2. REGN
  3. REGN News

Latest Regeneron Pharmaceuticals Inc. (REGN) News on September 18, 2025

Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD

GlobeNewswire

a day ago

Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD

Health Care Roundup: Market Talk

The Wall Street Journal

9 days ago

Health Care Roundup: Market Talk

Financial Services Roundup: Market Talk

The Wall Street Journal

a month ago

Financial Services Roundup: Market Talk

Morningstar Research

a month ago

Analyst Report: Sanofi

Share on Social Networks: